Prescription Drugs - Greece

  • Greece
  • In Greece, the revenue in the Prescription Drugs market is estimated to reach US$3.48bn in 2024.
  • The market is anticipated to exhibit a compound annual growth rate (CAGR 2024-2029) of 2.25%, resulting in a market volume of US$3.89bn by 2029.
  • When compared globally, United States is expected to generate the highest revenue of US$358.90bn in 2024.
  • In terms of per capita revenue, in Greece is projected to generate US$0.34k per person in 2024.
  • Despite economic challenges, Greece has seen a rise in the demand for generic prescription drugs due to cost-saving measures.

Key regions: Japan, China, Europe, Australia, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Prescription Drugs (Pharmacies) market in Greece has been experiencing significant growth in recent years, driven by various factors such as changing customer preferences, emerging trends in the market, and local special circumstances. Customer preferences in the Prescription Drugs (Pharmacies) market in Greece have shifted towards a greater emphasis on convenience and accessibility. Customers are increasingly looking for pharmacies that offer a wide range of prescription drugs and healthcare products, as well as additional services such as online ordering and home delivery. This trend is in line with global market preferences, as customers seek more convenient ways to access their medication. Trends in the market also contribute to the development of the Prescription Drugs (Pharmacies) market in Greece. One notable trend is the increasing demand for generic drugs. Generic drugs are more affordable alternatives to brand-name medications, and they are becoming increasingly popular among customers in Greece. This trend is driven by cost-conscious consumers who are looking for ways to save money on their healthcare expenses. Another trend in the market is the growing focus on preventive healthcare. Customers are becoming more proactive in managing their health and are seeking pharmacies that offer a range of preventive healthcare products and services. This includes vitamins, supplements, and health screenings. This trend is in line with global market trends, as preventive healthcare becomes increasingly important in maintaining overall well-being. Local special circumstances also play a role in the development of the Prescription Drugs (Pharmacies) market in Greece. One such circumstance is the country's aging population. Greece has one of the highest proportions of elderly population in Europe, which creates a higher demand for prescription drugs and healthcare services. This demographic factor contributes to the growth of the market, as pharmacies cater to the specific needs of the aging population. Underlying macroeconomic factors also impact the development of the Prescription Drugs (Pharmacies) market in Greece. Economic stability and government policies play a crucial role in shaping the market dynamics. For example, government initiatives to improve healthcare access and affordability can drive the growth of the market. Similarly, economic downturns or changes in healthcare regulations can have a negative impact on the market. In conclusion, the Prescription Drugs (Pharmacies) market in Greece is developing in response to changing customer preferences, emerging market trends, local special circumstances, and underlying macroeconomic factors. The emphasis on convenience and accessibility, the demand for generic drugs, the focus on preventive healthcare, the aging population, and government policies all contribute to the growth and evolution of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)